Heng, D. Y., MacKenzie, M. J., Vaishampayan, U. N., Bjarnason, G. A., Knox, J. J., Tan, M. H., . . . Choueiri, T. K. (2012). Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: Clinical characteristics, risk factors, and subsequent therapy. Oxford University Press.
Citação norma ChicagoHeng, D. Y., et al. Primary Anti-vascular Endothelial Growth Factor (VEGF)-refractory Metastatic Renal Cell Carcinoma: Clinical Characteristics, Risk Factors, and Subsequent Therapy. Oxford University Press, 2012.
Citação norma MLAHeng, D. Y., et al. Primary Anti-vascular Endothelial Growth Factor (VEGF)-refractory Metastatic Renal Cell Carcinoma: Clinical Characteristics, Risk Factors, and Subsequent Therapy. Oxford University Press, 2012.